| Trial ID: | L1252 |
| Source ID: | NCT00298883
|
| Associated Drug: |
Myfortic
|
| Title: |
Desensitization of Renal Transplant Candidates
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease|Kidney Transplantation
|
| Interventions: |
DRUG: Myfortic
|
| Outcome Measures: |
Primary: decrease in antibody reactivity, six weeks | Secondary: CBC and CMP values </> 2 times normal, six weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Florida | Collaborators: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
9
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-02
|
| Completion Date: |
2008-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-07-25
|
| Locations: |
University of Florida, Gainesville, Florida, 32610, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00298883
|
